1 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263. 2 Yang L,Kartsonaki C,Yao P,et al.The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China:a case-cohort study[J].Lancet Public Health,2021,6(12):888-896. 3 Morgan E,Soerjomataram I,Rumgay H,et al.The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040:new estimates from GLOBOCAN 2020[J].Gastroenterology,2022,163(3):649-658. 4 Holmberg D,Santoni G,von Euler-Chelpin MC,et al.Incidence and mortality in upper gastrointestinal cancer after negative endoscopy for gastroesophageal reflux disease[J].Gastroenterology,2022,162(2):431-438. 5 Plummer M,Franceschi S,Vignat J,et al.Global burden of gastric cancer attributable to Helicobacter pylori[J].Int J Cancer,2015,136(2):487-490. 6 Etemadi A,Safiri S,Sepanlou SG,et al.The global,regional,and national burden of stomach cancer in 195 countries,1990-2017:a systematic analysis for the Global Burden of Disease study 2017[J].Lancet Gastroenterol Hepatol,2020,5(1):42-54. 7 GBD 2021 Diseases and Injuries Collaborators.Global incidence,prevalence,years lived with disability(YLDs),disability-adjusted life-years(DALYs),and healthy life expectancy(HALE)for 371 diseases and injuries in 204 countries and territories and 811 subnational locations,1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet,2024,403(10440):2133-2161. 8 GBD 2021 Nervous System Disorders Collaborators.Global,regional,and national burden of disorders affecting the nervous system,1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet Neurol,2024,23(4):344-381. 9 Rosenberg PS,Check DP,Anderson WF.A web tool for age-period-cohort analysis of cancer incidence and mortality rates[J].Cancer Epidemiol Biomarkers Prev,2014,23(11):2296-2302. 10 Hauser DN,Hastings TG.Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism[J].Neurobiol Dis,2013,51:35-42. 11 成晓芬,闵淑慧,郭芮绮,等.1990—2019年中国胃癌发病与死亡率年龄-时期-队列分析及2020—2030年变化趋势预测[J].中国肿瘤,2023,32(6):454-461. 12 Fang EF,Xie C,Schenkel JA,et al.A research agenda for ageing in China in the 21st century(2nd edition):Focusing on basic and translational research,long-term care,policy and social networks[J].Ageing Res Rev,2020,64:101174. 13 Domper Arnal MJ,Ferrández Arenas Á,Lanas Arbeloa Á.Esophageal cancer:Risk factors,screening and endoscopic treatment in Western and Eastern countries[J].World J Gastroenterol,2015,21(26):7933-7943. 14 Camargo MC,Goto Y,Zabaleta J,et al.Sex hormones,hormonal interventions,and gastric cancer risk:a meta-analysis[J].Cancer Epidemiol Biomarkers Prev,2012,21(1):20-38. 15 Song Y,Liu X,Cheng W,et al.The global,regional and national burden of stomach cancer and its attributable risk factors from 1990 to 2019[J].Sci Rep,2022,12(1):11542. 16 Mahamud M,Islam MS,Wahed F,et al.Trend of carcinoma of the stomach in relation to site,age and aetiology:study of 112 cases in a tertiary level hospital[J].Mymensingh Med J,2021,30(2):395-401. 17 Machlowska J,Baj J,Sitarz M,et al.Gastric cancer:epidemiology,risk factors,classification,genomic characteristics and treatment strategies[J].Int J Mol Sci,2020,21(11):4012. 18 Toh JWT,Wilson RB.Pathways of gastric carcinogenesis,helicobacter pylori virulence and interactions with antioxidant systems,vitamin C and phytochemicals[J].Int J Mol Sci,2020,21(17):6451. 19 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. 20 Ahn YO.Diet and stomach cancer in Korea[J].Int J Cancer,1997,10:7-9. 21 Wang JM,Xu B,Hsieh CC,et al.Longitudinal trends of stomach cancer and esophageal cancer in Yangzhong County:a high-incidence rural area of China[J].Eur J Gastroenterol Hepatol,2005,17(12):1339-1344. 22 Trinh TTK,Lee K,Oh JK,et al.Cluster of lifestyle risk factors for stomach cancer and screening behaviors among Korean adults[J].Sci Rep,2023,13(1):17503. 23 Han B,Zheng R,Zeng H,et al.Cancer incidence and mortality in China,2022[J].J Natl Cancer Center,2024,4(1):47-53. 24 Cao M,Li H,Sun D,et al.Cancer burden of major cancers in China:a need for sustainable actions[J].Cancer Commun(Lond),2020,40(5):205-210. 25 Jiang Q,Shu Y,Jiang Z,et al.Burdens of stomach and esophageal cancer from 1990 to 2019 and projection to 2030 in China:findings from the 2019 Global Burden of Disease Study[J].J Glob Health,2024,14:04025. |